For instance, in colorectal cancer, the acute activation of PERK is required for cell death and is mediated by agents such as histone deacetylase inhibitors [171], the anti-inflammatory drugs sulindac [172], or ciclopirox, a wide-spectrum anticancer drug [173]. The gene discussed is EIF2AK3; the disease is colorectal cancer.